The amniotic membrane market is witnessing significant growth due to its numerous positive attributes. Amniotic membrane offers regenerative properties that aid tissue repair and healing, making it valuable in various medical applications. It promotes wound healing, reduces inflammation, and supports the growth of new cells. Additionally, the amniotic membrane exhibits antimicrobial properties, reduces scar formation, and provides a protective barrier. These beneficial characteristics have made amniotic membranes an increasingly preferred choice in ophthalmology, wound care, orthopedics, and other medical fields, driving the market's expansion.
Access Full Report @ https://www.databridgemarketresearch.com/reports/europe-amniotic-membrane-market
Data Bridge Market Research analyses that the Amniotic Membrane is growing with a CAGR of 8.1% in the forecast period of 2022 to 2029 and is expected to reach USD 304.39 million by 2029 from USD 166.50 million in 2021. The growing awareness among healthcare professionals and patients about the benefits and applications of amniotic membranes in regenerative medicine is leading to increased demand. As more healthcare professionals recognize its potential for tissue repair and regeneration, and patients seek effective treatment options, the market for amniotic membrane products is experiencing significant growth.
Key Findings of the Study
Growing geriatric population is expected to drive the market's growth rate
The growing geriatric population in Europe has contributed to the increased demand for amniotic membrane products in the region. Individuals become more susceptible to chronic diseases and age-related conditions, such as diabetic foot ulcers and venous leg ulcers that require advanced wound care solutions. Amniotic membrane products have shown effectiveness in promoting wound healing and tissue regeneration, making them a valuable treatment option for the aging population and driving the demand for these products in Europe.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014-2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Dehydrated Amniotic Membrane, Cryopreserved Amniotic Membrane, and Others), Application (Surgical Wounds, Ophthalmology, and Others), End User (Hospitals, Ambulatory Surgical Centers, Research Institutes and Academic Institutes and Specialty Clinics),
|
|
Countries Covered
|
Germany, France, U.K, Italy, Russia, Spain, Switzerland, Netherlands, Belgium, Turkey and Rest of Europe
|
|
Market Players Covered
|
Smith & Nephew plc (U.K.), Stryker (U.S.), Katena Products, Inc. (U.S.), The Electrospinning Company (U.K.), NuVision Biotherapies Ltd (U.K.), Amnio Technology, LLC (U.S.), Integra LifeSciences (U.S.), Organogenesis, Inc. (U.S.), MIMEDX (U.S.), Applied Biologics (U.S.), Skye Biologics Holdings, LLC (U.S.), Amniox Medical, Inc. (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The amniotic membrane market is segmented on the basis of product type, wound type, wound class, end user, and distribution channel.
- On the basis of product, the Europe amniotic membrane market is segmented into a cryopreserved amniotic membrane, dehydrated amniotic membrane, and others. In 2022, the dehydrated amniotic membrane segment is expected to dominate the product segment of the market with a CAGR of 8.4% in the forecast period of 2022 to 2029 due to the rising number of relatable products in the market and also a large number of beneficial effects of amniotic membranes.
In 2022, the dehydrated amniotic membrane segment is expected to dominate the product segment of the market
In 2022, the dehydrated amniotic membrane segment is expected to dominate the product segment of the market owing to the market's increasing availability of comparable goods and the many advantages of amniotic membranes with a CAGR of 8.4% in the forecast period of 2022 to 2029.
- On the basis of application, the Europe amniotic membrane market is segmented into surgical wounds, ophthalmology, and others. In 2022, the surgical wounds segment is expected to dominate the application segment of the market with a CAGR of 8.4% from 2022 to 2029 due to the increasing number of trauma and burn injuries due to road traffic accidents (RTA).
In 2022, the surgical wounds segment is expected to dominate the application segment of the market
In 2022, the surgical wounds segment is expected to dominate the application segment of the market owing to the rise in burns and other types of injuries brought on by traffic accidents, with a CAGR of 8.4% in the forecast period of 2022 to 2029.
- On the basis of end-user, the Europe amniotic membrane market is segmented into hospitals, ambulatory surgical centers, research institutes and academic institutes, and specialty clinics. In 2022, the hospitals segment is expected to dominate the end user segment of the market with a CAGR of 9.3% in the forecast period of 2022 to 2029 due to the number of burn injuries and trauma is increasing, and they require immediate surgery.
Major Players
Data Bridge Market Research recognizes the following companies as the major amniotic membrane market players in amniotic membrane market are Stryker (U.S.), Katena Products, Inc. (U.S.), The Electrospinning Company (U.K.), NuVision Biotherapies Ltd (U.K.), Amnio Technology, LLC (U.S.), Integra LifeSciences (U.S.), Organogenesis, Inc. (U.S.), MIMEDX (U.S.)
Market Development
- In 2022, Two new PalinGen membrane products, Dual Layer PalinGen X-Membrane and PalinGen Dual-Layer Membrane, have been introduced by Amnio Technology, a world leader in the development and distribution of amniotic tissue allografts. The new allografts are minimally altered, homologous use, and chorion-free, just like the entire family of PalinGen membrane products.
- In 2022, AcellFX (acellular amniotic membrane), which offers a protective environment or covering for repair to the ocular surface, is one of seven branded ophthalmic products that Laboratoires Thea SAS, one of the top independent pharmaceutical companies in Europe, has agreed to purchase from Akorn Operating Company LLC.
Regional Analysis
Geographically, the countries covered in the amniotic membrane market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and Rest of Europe in Europe
As per Data Bridge Market Research analysis:
Germany is the dominant region in amniotic membrane market during the forecast period 2022 - 2029
Germany is poised to experience significant growth in the amniotic membrane market during the forecast period. The country's rapidly increasing patient population, coupled with advancements in technology, is driving this growth. The rising prevalence of chronic wounds and age-related conditions necessitates effective wound care solutions, wherein amniotic membrane products play a vital role. Furthermore, Germany's strong healthcare infrastructure and focus on technological innovations position it as a key market for the adoption of amniotic membrane therapies, leading to promising growth prospects.
France is estimated to be the fastest growing region in amniotic membrane market the forecast period 2022 - 2029
France holds a prominent position in the amniotic membrane market as the second dominating country. This is primarily attributed to the country's growing healthcare infrastructure, which supports the adoption and utilization of advanced medical therapies. France's well-established healthcare facilities, specialized wound care centers, and research institutions create a conducive environment for the incorporation of amniotic membrane products in various therapeutic applications. The focus on enhancing patient care and the availability of advanced medical technologies contribute to France's significant role in the market's growth and development.
For more detailed information about the amniotic membrane market report, click here – https://www.databridgemarketresearch.com/reports/europe-amniotic-membrane-market
